首頁 > 市場調查報告書 > 製藥

藥物開發開發業務受託機關

市場調查報告書

商品編碼

1911896

皮膚病學CRO市場規模、佔有率和成長分析（按服務類型、皮膚病學適應症/治療領域、最終用戶和地區分類）－2026-2033年產業預測

Dermatology CRO Market Size, Share, and Growth Analysis, By Service Type (Pre-clinical Research Services, Clinical Research Services), By Dermatology Indication / Therapeutic Area (Psoriasis, Acne), By End-User, By Region - Industry Forecast 2026-2033

出版日期: 2026年01月01日 | 出版商:

SkyQuest | 英文 185 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球皮膚病學 CRO 市場規模預計在 2024 年達到 53.8 億美元，從 2025 年的 56.8 億美元成長到 2033 年的 87.1 億美元，在預測期（2026-2033 年）內複合年成長率為 5.5%。

受皮膚疾病盛行率上升和該領域藥物研發日益複雜化的推動，皮膚病學合約研究組織 (CRO) 市場正經歷強勁成長。隨著痤瘡、乾癬、濕疹、酒糟和皮膚癌等疾病的日益普遍，製藥和生物技術公司正加強研發力度，致力於開發創新治療方法。為了降低成本並縮短計劃週期，這些公司將臨床試驗外包給專業的皮膚病學 CRO。這些機構提供全面的服務，包括臨床前研究、製劑開發、臨床試驗管理、病患招募、法規諮詢和藥物警戒。皮膚病學通訊協定的專業知識對於管理涉及外用、口服和生物製藥的複雜研究至關重要，而對生物相似藥和生物製藥等先進製劑的需求進一步推動了這一趨勢。

推動全球皮膚科CRO市場發展的因素

全球皮膚病CRO市場的主要促進因素之一是皮膚疾病盛行率的不斷上升，這推動了對皮膚病領域專業臨床研究服務的需求。銀屑病、濕疹和痤瘡等疾病發病率的上升，以及人口老化導致老年人更容易出現皮膚問題，這些因素促使製藥和生物技術公司加大對皮膚病研究的投入。此外，治療方法和技術的進步也推動了對全面臨床試驗的需求，以確保新療法的安全性和有效性。這種日益成長的需求促使企業與合約研究組織（CRO）合作，以最佳化研究方法和結果。

全球皮膚病學CRO市場限制因素

影響全球皮膚病CRO市場的主要限制因素之一是皮膚病研究日益複雜化和監管挑戰。皮膚疾病種類繁多，要求CRO應對錯綜複雜的國內外法規，這會使研究設計和核准流程變得複雜。此外，進行針對特定皮膚疾病的臨床試驗需要專業知識，這會增加營運成本，並阻礙小規模機構進入市場。監管障礙和資金限制的雙重作用會延緩研發進程，最終抑制皮膚治療市場的成長和創新。

全球皮膚病學CRO市場趨勢

全球皮膚病學CRO市場的一個顯著趨勢是人工智慧（AI）、數位成像和遠端皮膚病學解決方案的日益普及。這些技術透過AI驅動的影像分析提高了皮膚評估的準確性，從而能夠更準確地評估治療效果、監測皮膚病變並改善疾病預後。隨著皮膚科CRO加速將這些數位工具整合到臨床試驗中，他們的目標是減少人為判斷造成的差異，並最佳化數據的準確性和可靠性。這種向技術輔助臨床評估的轉變有望徹底改變皮膚病學研究和患者照護的模式。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Parexel International
ICON plc
PPD（Thermo Fisher）
Charles River Laboratories
Syneos Health
IQVIA
Labcorp Drug Development
Covance（Labcorp）
Medpace Holdings
Wuxi AppTec
Clinipace
PRA Health Sciences
Pharmaron
Bioskin
Biorasi
Javara
TFS HealthScience
Accelovance
Clinigen Group
Bioforum

結論與建議

簡介目錄

Product Code: SQMIG35A3153

Global Dermatology CRO Market size was valued at USD 5.38 Billion in 2024 and is poised to grow from USD 5.68 Billion in 2025 to USD 8.71 Billion by 2033, growing at a CAGR of 5.5% during the forecast period (2026-2033).

The dermatology contract research organization (CRO) market is experiencing robust growth, driven by the rising prevalence of skin disorders and the increasing complexity of drug development in this field. As conditions such as acne, psoriasis, eczema, rosacea, and skin cancer become more common, pharmaceutical and biotechnology firms are intensifying their research efforts toward innovative therapies. To reduce costs and expedite project timelines, these companies are outsourcing their clinical trials to specialized dermatology CROs. These organizations provide comprehensive services, encompassing preclinical testing, formulation development, clinical trial management, patient recruitment, regulatory consulting, and pharmacovigilance. Their expertise in dermatological protocols is crucial for managing intricate studies on topical, oral, and biologic drugs, further propelled by the demand for advanced formulations like biosimilars and biologics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Dermatology CRO market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Dermatology CRO Market Segments Analysis

Global Dermatology CRO Market is segmented by Service Type, Dermatology Indication / Therapeutic Area, End-User and region. Based on Service Type, the market is segmented into Pre-clinical Research Services, Clinical Research Services, Regulatory & Medical Affairs Services and Consulting & Other Support Services. Based on Dermatology Indication / Therapeutic Area, the market is segmented into Psoriasis, Acne, Eczema / Atopic Dermatitis, Skin Cancer / Melanoma and Others. Based on End-User, the market is segmented into Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies (Dermatology Devices), Cosmetic and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Dermatology CRO Market

One key market driver for the Global Dermatology CRO Market is the increasing prevalence of skin disorders, which has heightened the demand for specialized clinical research services in dermatology. Factors such as rising incidences of conditions like psoriasis, eczema, and acne, coupled with an aging population more susceptible to skin issues, are prompting pharmaceutical and biotechnology companies to invest in dermatological research. Additionally, advancements in treatment methodologies and technologies are driving the need for comprehensive clinical trials that ensure the safety and efficacy of new therapies. This growing focus fosters collaboration with Contract Research Organizations (CROs) to optimize research processes and outcomes.

Restraints in the Global Dermatology CRO Market

One significant market restraint impacting the global dermatology Contract Research Organization (CRO) market is the increasing complexity and regulatory challenges associated with dermatological studies. The extensive range of dermatological conditions requires CROs to navigate a labyrinth of local and international regulations that can complicate study design and approval processes. Furthermore, the need for specialized expertise to conduct clinical trials tailored to specific skin conditions raises operational costs and can deter smaller organizations from entering the market. This combination of regulatory hurdles and financial constraints slows down research and development timelines, ultimately hindering market growth and innovation in dermatological therapies.

Market Trends of the Global Dermatology CRO Market

A prominent trend in the Global Dermatology Contract Research Organization (CRO) market is the growing adoption of artificial intelligence (AI), digital imaging, and teledermatology solutions. These technologies enhance the precision of skin evaluations through AI-driven image analysis, allowing for more accurate assessment of treatment outcomes, monitoring of skin lesions, and improved future disease prognosis. As dermatology CROs increasingly integrate these digital tools into their clinical studies, they aim to reduce variability stemming from human judgment, thereby optimizing data accuracy and reliability. This shift towards technology-assisted clinical assessment is poised to transform the landscape of dermatological research and patient care.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technology Assessment
Regulatory Landscape

Global Dermatology CRO Market Size by Service Type & CAGR (2026-2033)

Market Overview
Pre-clinical Research Services
Clinical Research Services
Regulatory & Medical Affairs Services
Consulting & Other Support Services

Global Dermatology CRO Market Size by Dermatology Indication / Therapeutic Area & CAGR (2026-2033)

Market Overview
Psoriasis
Acne
Eczema / Atopic Dermatitis
Skin Cancer / Melanoma
Others

Global Dermatology CRO Market Size by End-User & CAGR (2026-2033)

Market Overview
Pharmaceutical Companies
Biotechnology Companies
Medical Device Companies (Dermatology Devices)
Cosmetic
Others

Global Dermatology CRO Market Size & CAGR (2026-2033)

North America (Service Type, Dermatology Indication / Therapeutic Area, End-User)
- US
- Canada
Europe (Service Type, Dermatology Indication / Therapeutic Area, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Service Type, Dermatology Indication / Therapeutic Area, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Service Type, Dermatology Indication / Therapeutic Area, End-User)
- Brazil
- Rest of Latin America
Middle East & Africa (Service Type, Dermatology Indication / Therapeutic Area, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Parexel International
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ICON plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PPD (Thermo Fisher)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Charles River Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Syneos Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IQVIA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Labcorp Drug Development
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Covance (Labcorp)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medpace Holdings
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Wuxi AppTec
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Clinipace
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PRA Health Sciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pharmaron
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioskin
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biorasi
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Javara
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TFS HealthScience
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Accelovance
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Clinigen Group
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioforum
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments